Shortly after announcing positive data for Fibrin Pad, an experimental product for managing bleeding, Omrix said that it suspended the Phase II clinical trial "to investigate an incident of post-operative bleeding." The company says it will provide an update once additional information is available. Omrix release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/omrix-biopharmaceuticals-provides-update-fibrin-pad-u-s-phase-ii-clinical-trial-mild-